Farydak Interactions
There are 635 drugs known to interact with Farydak (panobinostat), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 348 are major, 285 are moderate, and 2 are minor.
- View all 635 medications that may interact with Farydak
- View Farydak alcohol/food interactions (1)
- View Farydak disease interactions (5)
Most frequently checked interactions
View interaction reports for Farydak (panobinostat) and the medicines listed below.
- Actemra (tocilizumab)
- acyclovir
- Adcetris (brentuximab)
- Adempas (riociguat)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Blincyto (blinatumomab)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Juxtapid (lomitapide)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Ofev (nintedanib)
- Orencia (abatacept)
- Pomalyst (pomalidomide)
- Prolia (denosumab)
- Promacta (eltrombopag)
- Ravicti (glycerol phenylbutyrate)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Sprycel (dasatinib)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Thalomid (thalidomide)
- Truvada (emtricitabine / tenofovir)
- Votrient (pazopanib)
- Zydelig (idelalisib)
Farydak alcohol/food interactions
There is 1 alcohol/food interaction with Farydak (panobinostat).
Farydak disease interactions
There are 5 disease interactions with Farydak (panobinostat) which include:
More about Farydak (panobinostat)
- Farydak consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: histone deacetylase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.